Search research articles
Contact Us
Filters
Showing results (31-40 of 119) with videos related to
Page
of 12
Sort By:
Gynecologic Oncology
|
November 24, 2012
Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer
Karin K Shih, Sarah A Milgrom, Nadeem R Abu-Rustum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 22, 2026
Incidence and clinical features of cataracts: an under-recognized adverse event with mirvetuximab soravtansine-gynx in ovarian cancer
Matthew L Flint, Anna Shvygin, Paul Johannet, et al.
BMC Women'S Health
|
October 29, 2021
Attributions of survival and methods of coping of long-term ovarian cancer survivors: a qualitative study
Dana Ketcher, Susan K Lutgendorf, Susan Leighton, et al.
Investigational New Drugs
|
October 18, 2011
A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors
Andrea Wang-Gillam, William P Tew, Mace L Rothenberg, et al.
Gynecologic Oncology
|
June 17, 2008
A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer
Jason Konner, Russell J Schilder, Felicia A DeRosa, et al.
Gynecologic Oncology
|
September 9, 2008
Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy
Oliver Zivanovic, Kaled M Alektiar, Yukio Sonoda, et al.
Journal of the American Geriatrics Society
|
February 6, 2023
Development and implementation of an interdisciplinary telemedicine clinic for older patients with cancer-Preliminary data
Koshy Alexander, Paul A Hamlin, William P Tew, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 24, 2013
Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies
Vaagn Andikyan, Fady Khoury-Collado, Samith Sandadi, et al.
Gynecologic Oncology
|
September 5, 2018
Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study
William P Tew, Michael W Sill, Joan L Walker, et al.
Gynecologic Oncology
|
March 28, 2021
Frailty based on the memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancer
Olga T Filippova, Amy L Tin, Joanne Alonso, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 119) with videos related to
Sort By:
Page
of 12
Gynecologic Oncology
|
November 24, 2012
Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer
Karin K Shih, Sarah A Milgrom, Nadeem R Abu-Rustum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 22, 2026
Incidence and clinical features of cataracts: an under-recognized adverse event with mirvetuximab soravtansine-gynx in ovarian cancer
Matthew L Flint, Anna Shvygin, Paul Johannet, et al.
BMC Women'S Health
|
October 29, 2021
Attributions of survival and methods of coping of long-term ovarian cancer survivors: a qualitative study
Dana Ketcher, Susan K Lutgendorf, Susan Leighton, et al.
Investigational New Drugs
|
October 18, 2011
A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors
Andrea Wang-Gillam, William P Tew, Mace L Rothenberg, et al.
Gynecologic Oncology
|
June 17, 2008
A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer
Jason Konner, Russell J Schilder, Felicia A DeRosa, et al.
Gynecologic Oncology
|
September 9, 2008
Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy
Oliver Zivanovic, Kaled M Alektiar, Yukio Sonoda, et al.
Journal of the American Geriatrics Society
|
February 6, 2023
Development and implementation of an interdisciplinary telemedicine clinic for older patients with cancer-Preliminary data
Koshy Alexander, Paul A Hamlin, William P Tew, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 24, 2013
Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies
Vaagn Andikyan, Fady Khoury-Collado, Samith Sandadi, et al.
Gynecologic Oncology
|
September 5, 2018
Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study
William P Tew, Michael W Sill, Joan L Walker, et al.
Gynecologic Oncology
|
March 28, 2021
Frailty based on the memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancer
Olga T Filippova, Amy L Tin, Joanne Alonso, et al.
Page
of 12